Janssen

Remicade - Cost

Updated as of: July 1st, 2024

HCPCS:

J1745

HCPCS Code Descriptor:

Injection, infliximab, excludes biosimilar, 10 mg

Medicare Payment Limit:

The Remicade Medicare Payment Limit is $31.707.

Average Sale Price:

Remicade ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The Remicade Medicare Co-insurance percentage is 31.707%. Remicade's Medicare Co-insurance amount is $6.341.

APC Code:

The Remicade APC Code is: 7043

APC Payment Limit:

The APC Payment Limit for Remicade is available. Login to view.

Remicade Cost Information:

Remicade's HCPCS was added January 1st, 2000. Up until March of 2017, Remicade took multiple, steady price increases every 6 months. In 2018, biosimilars for remicade began entering the market and it's ASP began to degrade. Between December 2017 and December of 2021 Remicade's ASP had degraded from $82.22 to $37.29, almost 55% degredation. On November 19th, 2021, Janssen released a second NDC for Remicade titled 'Infliximab', the generic name for Remicade. This drastically lowered the WAC and AWP pricing for Remicade in an attempt to compete with the lower-priced infliximab biosimilar alternatives.

ACCESS PRICING AND MORE BY REGISTERING

Remicade’s wholesale acquisition cost (WAC) information was last updated on:
July 1, 2019
Remicade’s average wholesale price (AWP) information was last updated on:
July 1, 2019